| Comprehensive molecular portraits of invasive lobular breast cancer G Ciriello, ML Gatza, AH Beck, MD Wilkerson, SK Rhie, A Pastore, ... Cell 163 (2), 506-519, 2015 | 1762 | 2015 |
| Proteogenomics connects somatic mutations to signalling in breast cancer P Mertins, DR Mani, KV Ruggles, MA Gillette, KR Clauser, P Wang, ... Nature 534 (7605), 55-62, 2016 | 1535 | 2016 |
| A pathway-based classification of human breast cancer ML Gatza, JE Lucas, WT Barry, JW Kim, Q Wang, M D. Crawford, ... Proceedings of the National Academy of Sciences 107 (15), 6994-6999, 2010 | 388 | 2010 |
| Anchorage-independent cell growth signature identifies tumors with metastatic potential S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ... Oncogene 28 (31), 2796-2805, 2009 | 388 | 2009 |
| An integrated genomics approach identifies drivers of proliferation in luminal-subtype human breast cancer ML Gatza, GO Silva, JS Parker, C Fan, CM Perou Nature genetics 46 (10), 1051-1059, 2014 | 282 | 2014 |
| Tumor mutational burden is a determinant of immune-mediated survival in breast cancer A Thomas, ED Routh, A Pullikuth, G Jin, J Su, JW Chou, KA Hoadley, ... Oncoimmunology 7 (10), e1490854, 2018 | 197 | 2018 |
| Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer P Kanlikilicer, R Bayraktar, M Denizli, MH Rashed, C Ivan, B Aslan, ... EBioMedicine 38, 100-112, 2018 | 177 | 2018 |
| NRF2 induction supporting breast cancer cell survival is enabled by oxidative stress–induced DPP3–KEAP1 interaction K Lu, AL Alcivar, J Ma, TK Foo, S Zywea, A Mahdi, Y Huo, TW Kensler, ... Cancer research 77 (11), 2881-2892, 2017 | 174 | 2017 |
| Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression J Liu, C Zhang, Y Zhao, X Yue, H Wu, S Huang, J Chen, K Tomsky, H Xie, ... Nature communications 8 (1), 1823, 2017 | 166 | 2017 |
| Using a stem cell–based signature to guide therapeutic selection in cancer I Shats, ML Gatza, JT Chang, S Mori, J Wang, J Rich, JR Nevins Cancer research 71 (5), 1772-1780, 2011 | 141 | 2011 |
| A genomic strategy to elucidate modules of oncogenic pathway signaling networks JT Chang, C Carvalho, S Mori, AH Bild, ML Gatza, Q Wang, JE Lucas, ... Molecular cell 34 (1), 104-114, 2009 | 139 | 2009 |
| Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades ML Gatza, JC Watt, SJ Marriott Oncogene 22 (33), 5141-5149, 2003 | 118 | 2003 |
| Genetic heterogeneity of Myc-induced mammary tumors reflecting diverse phenotypes including metastatic potential ER Andrechek, RD Cardiff, JT Chang, ML Gatza, CR Acharya, A Potti, ... Proceedings of the National Academy of Sciences 106 (38), 16387-16392, 2009 | 97 | 2009 |
| Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth CE Gatza, A Holtzhausen, KC Kirkbride, A Morton, ML Gatza, MB Datto, ... Neoplasia 13 (8), 758-IN28, 2011 | 82 | 2011 |
| SMAD4 suppresses WNT-driven dedifferentiation and oncogenesis in the differentiated gut epithelium AO Perekatt, PP Shah, S Cheung, N Jariwala, A Wu, V Gandhi, N Kumar, ... Cancer research 78 (17), 4878-4890, 2018 | 79 | 2018 |
| Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes ML Gatza, HN Kung, KL Blackwell, MW Dewhirst, JR Marks, JT Chi Breast Cancer Research 13, 1-17, 2011 | 77 | 2011 |
| New mechanisms of resistance to MEK inhibitors in melanoma revealed by intravital imaging HE Brighton, SP Angus, T Bo, J Roques, AC Tagliatela, DB Darr, ... Cancer research 78 (2), 542-557, 2018 | 71 | 2018 |
| Mediator kinase CDK8/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer A Serrao, LM Jenkins, AA Chumanevich, B Horst, J Liang, ML Gatza, ... Oncogene 37 (35), 4792-4808, 2018 | 57 | 2018 |
| Fibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment H Tian, J Liu, J Chen, ML Gatza, GC Blobe Oncogene 34 (45), 5635-5647, 2015 | 55 | 2015 |
| Amplification of SOX4 promotes PI3K/Akt signaling in human breast cancer GA Mehta, JS Parker, GO Silva, KA Hoadley, CM Perou, ML Gatza Breast cancer research and treatment 162, 439-450, 2017 | 54 | 2017 |
